Professional Summary

Professional Overview

Peter Berkowitz is an accomplished Finance Director with extensive experience in the pharmaceutical and biotechnology sectors. He currently serves as the Finance Director for the US Oncology division at EMD Serono, Inc., where he leverages his deep industry knowledge and financial expertise to drive strategic decision-making and operational excellence.

Experience Summary

Current Role

As the Finance Director for the US Oncology division at EMD Serono, Inc., Peter is responsible for overseeing the financial planning, analysis, and reporting for this critical business unit. He collaborates closely with cross-functional teams to ensure the alignment of financial strategies with the company's broader objectives, enabling the successful execution of key initiatives and the achievement of targeted financial goals.

Career Progression

Prior to his current role, Peter held various finance leadership positions at prominent pharmaceutical companies, including Biogen Idec and Merck. As the Finance Director for the Global Neurology & Immunology Franchise at EMD Serono, he played a pivotal role in driving financial performance and supporting the strategic expansion of the company's product portfolio. Earlier in his career, Peter gained valuable experience as a Senior Specialist and Associate Director in Financial Planning and Analysis at Merck.

Academic Background

Peter holds a Bachelor of Science degree in Finance and Accounting from the University of Pennsylvania, where he graduated with distinction.

Areas of Expertise

Peter's areas of expertise include financial planning and analysis, budget management, financial reporting, and strategic decision-making. He possesses a deep understanding of the pharmaceutical and biotechnology industries, which allows him to provide insightful financial guidance and support to his colleagues and stakeholders.

Professional Impact

Throughout his career, Peter has made significant contributions to the organizations he has served. In his previous role as the Finance Director for the Global Neurology & Immunology Franchise at EMD Serono, he spearheaded the implementation of a new financial planning and reporting platform, which enhanced the company's ability to make data-driven decisions and optimize resource allocation. Additionally, he led the financial integration of several key acquisitions, ensuring a seamless transition and the realization of anticipated synergies.

Conclusion

With his proven track record of financial leadership, strategic thinking, and industry expertise, Peter Berkowitz is well-positioned to continue driving success in his current role at EMD Serono. He is committed to leveraging his financial acumen and collaborative approach to support the company's growth and deliver sustainable value to its stakeholders.